European Academy of Allergy and Clinical Immunology
Tracked across 4 events · 27 articles · First seen Apr 27, 2026 · Last active Jun 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
Pharvaris, a late-stage biopharmaceutical company, announced the acceptance of one oral presentation and seven flash talk/poster presentations at the European Academy of Allergy and Clinical Immunology Annual Congress 2026 in Istanbul, Turkey, from June 12-15,…
Impact: The European Academy of Allergy and Clinical Immunology is hosting the Annual Congress 2026 where Pharvaris will present its clinical data, serving as a key platform for the event.
May 29, 2026 · 8 articles
Tech
Coya Therapeutics announced that data from its global Phase 3 HAELO clinical trial of Lonvoguran ziclumeran, a CRISPR-based gene editing therapy for hereditary angioedema (HAE), will be presented at the European Academy of Allergy and…
Impact: The European Academy of Allergy & Clinical Immunology (EAACI) is hosting the Annual Congress 2026 where the Phase 3 HAELO clinical trial data for Lonvoguran ziclumeran will be presented.
Jun 01, 2026 · 6 articles
Tech
Celldex Therapeutics announced that it will present three sets of clinical trial data for its drug candidates, Barzolvolimab and CDX-622, at the European Academy of Allergy and Clinical Immunology Annual Congress in Istanbul, Turkey, from…
Impact: The European Academy of Allergy and Clinical Immunology is hosting the annual congress where Celldex Therapeutics will present its clinical data.
Jun 10, 2026 · 6 articles
90
Pharvaris announced acceptance European Academy of Allergy and Clinical ImmunologyPharvaris Presents...
NEWSDESK
Track European Academy of Allergy and Clinical Immunology live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard